Pasithea Therapeutics Free Cash Flow (FCF) History (KTTA)
Pasithea Therapeutics reported −$12.8M in free cash flow for fiscal 2023, an increase of $1.8M from the previous fiscal year.
View full Pasithea Therapeutics company overviewPasithea Therapeutics free cash flow by year
2021
2022
2023
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$12.8M | $1.8M | — | — |
| 2022 | 2022-12-31 | −$14.7M | −$11.5M | — | −3014.85% |
| 2021 | 2021-12-31 | −$3.2M | — | — | −21216.05% |
Pasithea Therapeutics quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | −$3.3M | $1.2M | — | — |
| Q3 2023 | 2023-09-30 | −$3.3M | $2.0M | — | — |
| Q2 2023 | 2023-06-30 | −$3.1M | −$698,805 | — | — |
| Q1 2023 | 2023-03-31 | −$3.3M | −$726,737 | — | — |
| Q4 2022 | 2022-12-31 | −$4.5M | — | — | −1874.20% |
| Q3 2022 | 2022-09-30 | −$5.2M | — | — | −2398.91% |
| Q2 2022 | 2022-06-30 | −$2.4M | — | — | −17553.71% |
| Q1 2022 | 2022-03-31 | −$2.5M | — | — | −18519.76% |
Pasithea Therapeutics free cash flow growth trends
Pasithea Therapeutics's latest reported quarter, Q4 2023, generated −$3.3M in free cash flow, an increase of $1.2M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Pasithea Therapeutics source filings ↗